Christopher W. Fulton

Array ( [id] => 3981692 [patent_doc_number] => 05948895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Process for producing a glycosylated amino compound' [patent_app_type] => 1 [patent_app_number] => 8/893161 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2052 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948895.pdf [firstpage_image] =>[orig_patent_app_number] => 893161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409929 [patent_doc_number] => 06265413 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Camptothecin compounds and a method of preparation thereof' [patent_app_type] => 1 [patent_app_number] => 8/860655 [patent_app_country] => US [patent_app_date] => 1997-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14007 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265413.pdf [firstpage_image] =>[orig_patent_app_number] => 860655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504036 [patent_doc_number] => 06465421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Modulating body/cranial hair growth' [patent_app_type] => B1 [patent_app_number] => 08/886157 [patent_app_country] => US [patent_app_date] => 1997-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4072 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465421.pdf [firstpage_image] =>[orig_patent_app_number] => 08886157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531833 [patent_doc_number] => 06410258 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Molecular hydrogen production by direct electron transfer' [patent_app_type] => B1 [patent_app_number] => 08/879920 [patent_app_country] => US [patent_app_date] => 1997-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7609 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410258.pdf [firstpage_image] =>[orig_patent_app_number] => 08879920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4142865 [patent_doc_number] => 06060586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Ureins derived from alpha, omega-diamono acids and process for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/985658 [patent_app_country] => US [patent_app_date] => 1997-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4580 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060586.pdf [firstpage_image] =>[orig_patent_app_number] => 985658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1022162 [patent_doc_number] => 06888033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Anti-viral compounds' [patent_app_type] => utility [patent_app_number] => 09/202359 [patent_app_country] => US [patent_app_date] => 1997-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9592 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/888/06888033.pdf [firstpage_image] =>[orig_patent_app_number] => 09202359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872731 [patent_doc_number] => 05824556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Peptide mass ladders generated using carbon disulfide' [patent_app_type] => 1 [patent_app_number] => 8/872888 [patent_app_country] => US [patent_app_date] => 1997-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4766 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824556.pdf [firstpage_image] =>[orig_patent_app_number] => 872888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4005943 [patent_doc_number] => 05859188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method for discovering novel anthelmintic compounds' [patent_app_type] => 1 [patent_app_number] => 8/866845 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3540 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859188.pdf [firstpage_image] =>[orig_patent_app_number] => 866845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1308297 [patent_doc_number] => 06617422 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Peptide nucleic acid monomers and oligomers' [patent_app_type] => B1 [patent_app_number] => 08/862629 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14187 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617422.pdf [firstpage_image] =>[orig_patent_app_number] => 08862629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051839 [patent_doc_number] => 05932551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents' [patent_app_type] => 1 [patent_app_number] => 8/848766 [patent_app_country] => US [patent_app_date] => 1997-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20049 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 949 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932551.pdf [firstpage_image] =>[orig_patent_app_number] => 848766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763600 [patent_doc_number] => 05844077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Use of conantokins for producing analgesia or for neuroprotection' [patent_app_type] => 1 [patent_app_number] => 8/847848 [patent_app_country] => US [patent_app_date] => 1997-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6943 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/844/05844077.pdf [firstpage_image] =>[orig_patent_app_number] => 847848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942754 [patent_doc_number] => 05981691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Imide-free and mixed amide/imide thermal synthesis of polyaspartate' [patent_app_type] => 1 [patent_app_number] => 8/842016 [patent_app_country] => US [patent_app_date] => 1997-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 16609 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981691.pdf [firstpage_image] =>[orig_patent_app_number] => 842016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105457 [patent_doc_number] => 06100376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'A.sup.21, B.sup.30, modified insulin derivatives having an altered action profile' [patent_app_type] => 1 [patent_app_number] => 8/842794 [patent_app_country] => US [patent_app_date] => 1997-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3786 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100376.pdf [firstpage_image] =>[orig_patent_app_number] => 842794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234419 [patent_doc_number] => 06117840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'CS-1 peptidomimetics, compositions and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/837154 [patent_app_country] => US [patent_app_date] => 1997-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 21817 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117840.pdf [firstpage_image] =>[orig_patent_app_number] => 837154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035949 [patent_doc_number] => 05942608 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Process for preparing a universal support for the synthesis of oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/829166 [patent_app_country] => US [patent_app_date] => 1997-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6763 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 321 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942608.pdf [firstpage_image] =>[orig_patent_app_number] => 829166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940331 [patent_doc_number] => 05973111 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Inhibitors of interleukin-1.beta. converting enzyme' [patent_app_type] => 1 [patent_app_number] => 8/828941 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59672 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973111.pdf [firstpage_image] =>[orig_patent_app_number] => 828941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926239 [patent_doc_number] => 05945508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Substance P treatment for immunostimulation' [patent_app_type] => 1 [patent_app_number] => 8/829445 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6570 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945508.pdf [firstpage_image] =>[orig_patent_app_number] => 829445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995703 [patent_doc_number] => 05922594 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Method of producing bilayer lipid membranes' [patent_app_type] => 1 [patent_app_number] => 8/809617 [patent_app_country] => US [patent_app_date] => 1997-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2976 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922594.pdf [firstpage_image] =>[orig_patent_app_number] => 809617 [rel_patent_id] =>[rel_patent_doc_number] =>)